Digital Radiology has been optimising the wrong metric Report turnaround time has become a key metric for diagnostic centres, shaping much of the automation built around their work.
Digital AI is redefining decision-making in biopharma R&D AI has kickstarted a new wave of innovation in biopharma R&D.
Digital The future of feasibility: AI-driven site selection & protoc... AI can help sponsors identify higher-potential sites, improve enrolment predictability, and accelerate study startup timelines.
Digital Fail fast is not a cultural problem. It is a capital allocat... Even modest improvements in early predictive resolution can materially shift portfolio economics.
R&D AI in clinical development & ‘white space’, with Andrew Mack... Andrew Mackinnon, senior vice president and executive general manager at Medable, discusses leveraging AI to transform & accelerate development.
R&D From complexity to cohesion: AI’s growing role in building s... AI is being used from protocol design to study start-up and through clinical trial closeout, reshaping the trial lifecycle.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.